Overcoming Challenges In CGT Development

Reliability is paramount when developing cell and gene therapies. Today, the end-product costs are a major focus and will be in the future as advanced therapies mature and continue to become more widely used. The challenges and costs associated with a therapy approval can reach hundreds of thousands of dollars per dose, which makes the cell and gene therapy manufacturing process critical. Sterile connectors can help save time and money in this process. CPC will discuss connector solutions for sterility, chemical compatibility, and ultra-low temperature challenges when setting up a therapeutic process for long-term success.

1. Improving operations to make more reliable, faster, and easier sterile connections.
2. A complete and validated method for sterile fluid transfer without Bios Safety Cabinets or capital equipment expenditures.
3. How aseptic connector solutions support scale-up and scale-out while addressing processing concerns.

Presented by Troy Ostreng; Senior Product Manager at CPC

Recording provided with permission from GEN Publishing